C07D 473/22
One oxygen and one sulfur atom
Official title: one oxygen and one sulfur atom
C07D473/22 (One oxygen and one sulfur atom) appears on 35 US grants and 29 published applications in this corpus.
Search patents in C07D- Granted patents
- 35
- Published applications
- 29
- Assignees
- 23
- Inventors
- 95
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 3 |
| 2008 | 1 | 3 |
| 2009 | 1 | 4 |
| 2010 | 0 | 0 |
| 2011 | 2 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 4 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 3 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 3 |
| 2024 | 1 | 2 |
| 2025 | 1 | 0 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Purine compounds for treating disorders10 Mar 2026US 12,570,656 B2Marvel Biotechnology
- Small molecule PARG inhibitors and methods of use thereof9 Dec 2025US 12,491,188 B2Board of Regents, The University of Texas System
- PAPD5 inhibitors and methods of use thereof24 Dec 2024US 12,171,755 B2Children's Medical Center Corporation
- Nitrogen-containing heterocyclic compound, preparation method, intermediate, pharmaceutical composition and use10 Aug 2021US 11,084,818 B2Hepo Pharmaceutical Co., Ltd.
- Papd5 inhibitors and methods of use thereof30 Apr 2026US 2026/0115182 A1Children's Medical Center Corporation
- Inhibitors of myeloperoxidase23 May 2024US 2024/0166642 A1AstraZeneca AB
- Poly(adp-ribose) glycohydrolase (parg) inhibitors against covid macrodomain and methods of using the same4 Apr 2024US 2024/0109892 A1
- Broad spectrum anti-cancer compounds12 Oct 2023US 2023/0322715 A1The Regents of the University of California
- Purine compounds for treating disorders18 May 2023US 2023/0151011 A1Marvel Biotechnology
Most cited
By later US patents
- Xanthine derivatives50US 4,879,296 ABurroughs Wellcome Co. · 1989
- Xanthine derivatives39US 5,068,236 AKyowa Hakko Kogyo Co., Ltd. · 1991
- Xanthine derivatives28US 5,290,782 AKyowa Hakko Kogyo Co., Ltd. · 1994
- Pyrimidine and purine derivatives and their use in treating tumour cells23US 5,929,046 ACancer Research Campaign Technology Limited · 1999
- 6-thioxanthines21US 4,925,847 AEuroceltique, S.A. · 1990